Lb Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lb Pharmaceuticals Inc's ROI in the second quarter of 2026?
Lb Pharmaceuticals Inc recorded a cumulative net loss of $-61 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -20.51%.

Within the Healthcare sector 249 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2813 to 2890.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) III. Quarter
Y / Y Investment Change TTM	733.83 %	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	338	383	144	315	142
Return On Investment (TTM)	-20.51 %	-5.6 %	-0.02 %	38.77 %	94.99 %
LBRX's Overall Ranking	# 2890	# 2813	# 0	#	#
Seq. Investment Change TTM	19.99 %	63.86 %	31.53 %	222.44 %	-
Seq. Net Income Change TTM	-	-	-	31.61 %	209.81 %
Net Income (TTM) in Millions	-61	-14	0	44	34

LBRX Company Profile >> Back to LBRX Roi Comparisons >> See Annual LBRX Return On Investment

Return On Investment LBRX's Ranking
Within:	No.
Industry	# 88
Sector	# 250
Overall	# 2890

Return On Investment Statistics
High	Average	Low
-0.02 %	-7.66 %	-20.51 %
		(Jun 30 2026)

Financial Statements
Lb Pharmaceuticals Inc's II. Quarter Investments	$ 338 Millions	LBRX's Balance sheet
Lb Pharmaceuticals Inc's II. Quarter Income	$ -52 Millions	Quarterly LBRX's Income Statement
LBRX's Income by Division		See LBRX's Income by Division

LBRX Annual Return On Investment	(Dec 31 2024) 2025
Total Investments in Millions	142	0	0	0	0
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	0	0	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-0.04 %	-	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LBRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LBRX's Competitors
Subscribers only: Roi for Lb Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for LBRX's Customers

Other Ratios
LBRX's Roa	LBRX's Inventory Turnover Ratio	LBRX's Growth Rates	LBRX's Dividend Statistics
	LBRX's Profitability Ratios	LBRX's Asset Turnover Ratio	LBRX's Dividend Growth
LBRX's Roe	LBRX's Valuation Ratios	LBRX's Financial Strength Ratios	LBRX's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:43:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.